Image

Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury

Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury

Recruiting
21-80 years
All
Phase N/A

Powered by AI

Overview

Acute intermittent hypoxia (AIH) involves 1-2min of breathing low oxygen air to stimulate neuroplasticity. Animal and human studies show that AIH improves motor function after neural injury, particularly when paired with task-specific training. Using a double blind cross-over study we will test whether AIH and task-specific airway protection training improves airway protection more than training alone in individuals with chronic mild-moderate traumatic brain injury (TBI).

Description

Recent studies have found that acute intermittent hypoxia (AIH)-or repetitive exposure to brief episodes of low inspired oxygen--is a promising new strategy that can help restore motor function by promoting neuroplasticity throughout the central nervous system (CNS). Both rodent and human studies show that motor function is further enhanced when AIH is paired with task-specific training/rehabilitation (TST). Therefore, this study will investigate the therapeutic potential of combining AIH with a task-specific airway protection training. We propose that the combined use of AIH + TST will enhance the magnitude and duration of TST training alone in individuals with chronic traumatic brain injury.

Eligibility

Inclusion Criteria:

  • Adults aged 21-80 years
  • A mild to moderate traumatic brain injury (TBI) confirmed by medical records
  • A Glasgow Coma Scale score between 9-15
  • Able to consent independently
  • Women of child-bearing age must be comfortable confirming a negative pregnancy prior to participating in the study

Exclusion Criteria:

  • Other neurological diagnoses or a diagnosis of a severe psychiatric disorder
  • Severe aphasia preventing a participant from understanding the protocol and consent form
  • Pre-existing hypoxic pulmonary disease
  • History of obstructive lung diseases such as chronic obstructive pulmonary disease (COPD) or significant asthma)
  • Severe hypertension (>160/100)
  • History of head and neck cancer
  • Allergy to barium sulfate
  • Ischemic cardiac disease

Study details
    Traumatic Brain Injury

NCT06520358

University of Florida

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.